Market revenue in 2024 | USD 272.9 million |
Market revenue in 2030 | USD 454.7 million |
Growth rate | 8.8% (CAGR from 2025 to 2030) |
Largest segment | Food & beverages |
Fastest growing segment | Dietary Supplements |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Food & Beverages, Dietary Supplements |
Key market players worldwide | Danone SA, Yakult Honsha Co Ltd, United Natural Foods Inc, Pfizer Inc, Sabinsa Corporation, Probiotical, Synbiotic Health, NUtech Ventures |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to synbiotic product market will help companies and investors design strategic landscapes.
Food & beverages was the largest segment with a revenue share of 89.15% in 2024. Horizon Databook has segmented the North America synbiotic product market based on food & beverages, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
The growing prevalence of prebiotics, probiotics, and synbiotics in North America on account of their potential use as nutritional supplements is likely to boost the demand for synbiotic products in the upcoming years.
Due to the pandemic, a majority of the consumers are consciously adopting synbiotics and related supplements to improve physical health, treat obesity, and reduce the risk of heart diseases. Consumers are increasingly opting for synbiotic products since they act synergistically to improve overall gut health by offering more benefits than either a probiotic or prebiotic agent alone.
Additional benefits offered by these products include developing immune systems; treating intestinal defects; activating metabolism; treating allergy; and treating cancer, liver disease, pancreatitis, and irritable bowel syndrome in surgical patients. Since these products promote overall health and wellbeing, they have witnessed an increased demand over the past few years.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America synbiotic product market, including forecasts for subscribers. This continent databook contains high-level insights into North America synbiotic product market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account